Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Wien Klin Wochenschr. 2021 Sep;133(17-18):931-941. doi: 10.1007/s00508-021-01922-y. Epub 2021 Aug 10.
Wien Klin Wochenschr. 2021.
PMID: 34378087
Free PMC article.
Clinical Trial.
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L; HERALD Study Group.
Kremsner PG, et al. Among authors: schonborn kellenberger o.
Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23.
Lancet Infect Dis. 2022.
PMID: 34826381
Free PMC article.
Clinical Trial.
Item in Clipboard
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Blank A, Hohmann N, Dettmer M, Manka-Stuhlik A, Mikus G, Stoll F, Stützle-Schnetz M, Thomas D, Exner E, Schmitt-Bormann B, Schaller T, Laage R, Schönborn-Kellenberger O, Arndt M, Haefeli WE, Krauss J.
Blank A, et al. Among authors: schonborn kellenberger o.
Clin Transl Sci. 2022 Oct;15(10):2366-2377. doi: 10.1111/cts.13365. Epub 2022 Jul 23.
Clin Transl Sci. 2022.
PMID: 35869929
Free PMC article.
Clinical Trial.
Item in Clipboard
Tachykinin Antagonists Reverse Ischemia/Reperfusion Gastrointestinal Motility Impairment in Rats.
Umer A, Ługowska-Umer H, Schönborn-Kellenberger O, Korolkiewicz PK, Sein-Anand Ł, Kuziemski K, Korolkiewicz RP.
Umer A, et al. Among authors: schonborn kellenberger o.
J Surg Res. 2020 Nov;255:510-516. doi: 10.1016/j.jss.2020.05.092. Epub 2020 Jul 3.
J Surg Res. 2020.
PMID: 32629333
Item in Clipboard
Tachykinin antagonists ameliorate surgically induced impairment of gastrointestinal motility in rats.
Umer A, Ługowska-Umer H, Schönborn-Kellenberger O, Korolkiewicz PK, Sein-Anand Ł, Kocic I, Korolkiewicz RP.
Umer A, et al. Among authors: schonborn kellenberger o.
Fundam Clin Pharmacol. 2021 Aug;35(4):681-689. doi: 10.1111/fcp.12616. Epub 2020 Nov 5.
Fundam Clin Pharmacol. 2021.
PMID: 33058252
Item in Clipboard
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
Hanna GJ, Stathis A, Lopez-Miranda E, Racca F, Quon D, Leyvraz S, Hess D, Keam B, Rodon J, Ahn MJ, Kim HR, Schneeweiss A, Ribera JM, DeAngelo D, Perez Garcia JM, Cortes J, Schönborn-Kellenberger O, Weber D, Pisa P, Bauer M, Beni L, Bobadilla M, Lehal R, Vigolo M, Vogl FD, Garralda E.
Hanna GJ, et al. Among authors: schonborn kellenberger o.
Cancer Res Commun. 2023 Sep 14;3(9):1853-1861. doi: 10.1158/2767-9764.CRC-23-0333.
Cancer Res Commun. 2023.
PMID: 37712875
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite